Calcium Citrate Versus Calcium Carbonate in the Management of Chronic Hypoparathyroidism: A Randomized, Double‐Blind, Crossover Clinical Trial

In hypoparathyroidism (HypoPT), calcium supplementation is virtually always required, although the disease is likely to be associated with an increased risk of nephrolithiasis. The use of calcium citrate (Ca‐Cit) theoretically could have a positive impact on the nephrolithiasis risk because citrate...

Descripción completa

Detalles Bibliográficos
Autores principales: Naciu, Anda Mihaela, Tabacco, Gaia, Bilezikian, John P, Santonati, Assunta, Bosco, Daniela, Incognito, Giosuè Giordano, Gaspa, Gianluigi, Manfrini, Silvia, Falchetti, Alberto, Trimboli, Pierpaolo, Mazziotti, Gherardo, Napoli, Nicola, Sanson, Gianfranco, Cesareo, Roberto, Vescini, Fabio, Palermo, Andrea
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2022
Materias:
Clinical Trial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9542059/
https://www.ncbi.nlm.nih.gov/pubmed/35466449
http://dx.doi.org/10.1002/jbmr.4564

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9542059/
https://www.ncbi.nlm.nih.gov/pubmed/35466449
http://dx.doi.org/10.1002/jbmr.4564

Ejemplares similares